Skip to main content
Mohamed Hegazi, MD, Oncology, Louisville, KY

Mohamed Hegazi MD

Hematologic Oncology


Director, Blood Cancer, Cellular Therapeutics and Transplant (BCT) program

Join to View Full Profile
  • 529 S Jackson StLouisville, KY 40202

  • Phone+1 502-562-4270

  • Fax+1 502-562-4373

Dr. Hegazi is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • University of Louisville School of Medicine
    University of Louisville School of MedicineFellowship, Hematology and Medical Oncology, 2018
  • Jersey Shore University Medical Center
    Jersey Shore University Medical CenterResidency, Internal Medicine, 2015
  • Mansoura University Faculty of Medicine
    Mansoura University Faculty of MedicineClass of 2009

Certifications & Licensure

  • KY State Medical License
    KY State Medical License 2015 - 2026
  • NJ State Medical License
    NJ State Medical License 2013 - 2017
  • Internal Medicine
    American Board of Internal Medicine Internal Medicine
  • Hematology
    American Board of Internal Medicine Hematology
  • Medical Oncology
    American Board of Internal Medicine Medical Oncology

Clinical Trials

Publications & Presentations

PubMed

Lectures

  • Healthcare implications of Clodtridium difficile infection after bone marrow transplant: Nationwide Readmission Database review. 
    2019 ASCO Annual Meeting - 6/1/2019

Press Mentions

  • Million-Dollar Donation Will Fund Advanced Cancer Treatment at UofL Hospital
    Million-Dollar Donation Will Fund Advanced Cancer Treatment at UofL HospitalOctober 15th, 2019

Other Languages

  • Arabic

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: